This study aimed to investigate the involvement of adenosine receptors in the interaction between paracetamol and caffeine. Nociception was studied in mice, using paracetamol, caffeine, the A 2A antagonist, 5-amino-7-(ß-phenylethyl)-2-(8- 
Introduction
The adenosine receptor family comprises four subtypes: A 1, A 2A, A 2B and A 3 . A 1 receptors are widely distributed in brain, spinal cord and periphery ) while A 2A receptors are predominantly expressed in the periphery (Dunwiddle and Masino, 2001) , with only a very restricted central expression in the striatum, nucleus accumbens and olfactory tubercle (Jarvis and Williams, 1989) . A 2B and A 3 receptors are widely distributed, but are present at a low density in the central nervous system (Feoktistov and Biaggioni, 1997; Rivkees et al., 2000) . Within the spinal cord adenosine acts to suppress nociceptive signalling, mediated via the A 1 receptor (DeLander and Hopkins, 1986; Holmgren et al., 1986) , while in the periphery it has an algogenic activity which may be mediated via an A 2 receptor subtype (McQueen and Ribeiro, 1986 ; see Sawynok and Yaksh, 1993) . In the mouse the location of these receptors are most probably on sensory nerves as there is no A 2A receptor binding in the spinal cord (Bailey et al., 2002b; Kelly et al., 2004) .
Caffeine is a non-specific adenosine antagonist and binds A 1 and A 2 receptors with equal affinity, but does not bind A 3 receptors (see Fredholm and Lindstrom, 1999) . It is used in combination with non-steroidal anti-inflammatory drugs as an analgesic adjuvant (Sawynok and Yaksh, 1993) . In mice, rats and humans caffeine increases the antinociceptive effects of paracetamol (Laska et al., 1983; Granados-Soto et al., 1993; Engelhardt et al., 1997) . When used alone caffeine has been shown to cause antinociception in rats and mice (Sawynok et al., 1995; Ghelardini et al., 1997; AboSalem et al., 2004) .
It is unclear how caffeine produces its analgesic effect, but it is likely to be via adenosine receptor antagonism (Fredholm et al., 1996) . The analgesic adjuvant effects of caffeine cannot be due to A 1 receptor blockade, as stimulation of A 1 4 receptors is known to be antinociceptive (Sawynok and Liu, 2003) , genetically modified mice lacking the A 1 receptor are hyperalgesic (Johansson et al., 2001; Wu et al., 2005) and A 1 antagonists are pronociceptive (Bastia et al., 2002) or ineffective in animal models of pain (Abo-Salem et al., 2004) . Abo-Salem et al (2004) demonstrated that novel selective A 2B adenosine receptor antagonists produced a similar antinociception to caffeine in the hot plate test in mice, raising the possibility that part of the action of caffeine might be mediated at the A 2B receptor. Although they also reported that adenosine A 2A antagonists were not antinociceptive (AboSalem et al., 2004) , others have shown antinociceptive effects of A 2A antagonists in the writhing test (Bastia et al., 2002) . Further, mice deficient in the adenosine A 2A receptor gene display hypoalgesia (Ledent et al., 1997; Bailey et al., 2002a) , raising the possibility that both A 2 subtypes are involved in nociceptive modulation.
The aim of this study was to compare the effect of caffeine on paracetamol-induced antinociception with that of selective antagonists for A 2A and A 2B receptors. To address this we have studied the effects of paracetamol and caffeine alone and in combination in mice, using the hot plate and tail immersion nociceptive tests and also the effect of 5-amino-7-(ß-phenylethyl)-2-(8-furyl)pyrazolo [4,3- 
Materials and Methods

Wild type and adenosine A 2A receptor knockout mice
The mice used in this study were derived from a breeding colony of adenosine A 2A receptor knockout mice on a CD-1 background (Ledent et al., 1997) maintained at the University of Surrey. Matings between heterozygote (+/-) animals produced wildtype (+/+), heterozygote (+/-) and knockout (-/-) animals, and the genotype of the animals was established at 21 days by tail tipping and DNA amplification using PCR (Ledent et al., 1997) . The majority of studies were carried out in the wildtype mice, but in some studies with paracetamol and caffeine the knockout mice were used. After weaning, all animals were housed three per cage in an air conditioned unit maintained at 20-22°C and 50-60 % humidity and were allowed free access to standard rodent chow and water. Lighting was controlled on a twelve-hour cycle, lights on at 07.00 hr.
Animals were acclimatised to the procedure room for 2 hr prior to testing at 11.00 hr.
All protocols were carried out in accordance with the Animals (Scientific Procedures) Act, 1984 and approved by a local ethical committee.
Drug treatment
Mice weighing 25-30 g received paracetamol, caffeine, the A 2B antagonist PSB1115 (Fredholm et al., 1998; Abo-Salem et al., 2004) or the A 2A antagonist SCH58261 (Zocchi et al., 1996; Fredholm et al., 1998; Abo-Salem et al., 2004 ) alone or in combination. All drugs were injected intraperitoneally (i.p.) in a volume of 8 ml/kg.
Control groups were given drug vehicle (see Materials) in an equal volume.
Tail immersion test
Mice were restrained in a plastic tube with the tail exteriorised and a thermal stimulus was applied by immersion of approximately 3 cm of the tip of the tail in a thermostatically controlled water-bath kept at a temperature of 53 ± 0.1°C. Latencies for tail withdrawal were recorded for each animal before and after drug administration using a hand-held stopwatch. A 10 s cut-off time was imposed to avoid tissue damage.
Hot plate
In a modification of the method of Chen (1951) , a 3 mm aluminium plate was placed in a thermostatically controlled water-bath kept at a constant temperature of 55 ± 0.1°C. The latency for nociceptive response (defined as paw licking or jumping) was recorded for each animal before and after drug administration using a hand-held stopwatch. A 30 s cut-off time was imposed to avoid tissue damage.
Statistical analysis
Statistical comparison of the drug-treated groups was performed using two-way ANOVA (for factors treatment and time) with repeated measures, followed by Scheffe's post hoc test. P<0.05 was considered significant. Comparison of basal nociceptive latencies between wildtype and knockout animals were performed using unpaired Student's t-test.
Materials
Paracetamol and caffeine were purchased from Sigma-Aldrich (Dorset, UK) and dissolved in warmed PBS (Oxoid, Hampshire, UK). SCH58261 (Sigma-Aldrich, Dorset, UK) was dissolved in DMSO (5 mg/ml) which was further diluted in PBS to give a final concentration of 15 % DMSO (Fischer Scientific, Loughborough, UK) in the drug injection solution. PSB1115 was dissolved in PBS and was a kind gift from Prof. Christa Müller (Bonn University, DE).
Results
Effects of paracetamol and caffeine in the tail immersion test.
The basal response latency of all mice prior to drug administration was 2.23 ± 0.15 s.
Paracetamol (50-200 mg/kg) administered alone produced significant antinociception (P<0.01) at all time points, while 10 mg/kg paracetamol was without effect (Fig. 1A) .
Caffeine (10 mg/kg) administered alone produced a pronociceptive effect which was significant at 15 and 30 min (Fig. 1B) . Caffeine (10 mg/kg) abolished the antinociceptive effect of paracetamol (50-200 mg/kg) (Fig. 1B,C) .
In a further series of experiments caffeine and paracetamol were administered to A 2A receptor knockout mice, but the basal response latency of all A 2A knockout mice prior to drug administration was 3.40 ± 0.16 s, significantly higher than the wildtype control, (P<0.05). In these mice paracetamol even at high doses (100-200 mg/kg) and caffeine (10 mg/kg) administered alone or in combination failed to increase nociceptive response latencies further.
The effect of SCH58261 and PSB1115 on the antinociceptive response to paracetamol in the tail immersion test.
Paracetamol (50 mg/kg) or the A 2A antagonist SCH58261 (3 mg/kg) administered alone produced significant antinociception, but in the presence of SCH58261 paracetamol was unable to induce a further increase in response latency (Fig. 2A) .
The A 2B antagonist PSB1115 (10 mg/kg) administered alone did not produce significant antinociception, but abolished the effect of paracetamol (50 mg/kg) (Fig.   2B ).
Effects of paracetamol, caffeine and adenosine receptor antagonists in the hot
plate test.
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The basal response latency of all mice prior to drug administration was 8.03 ± 0.39 s.
Paracetamol administered alone (10-200 mg/kg) produced significant antinociception (P<0.01) at 30 min (Fig. 3A) . Caffeine (10 mg/kg) administered alone had no effect on nociceptive response latencies (Fig. 3B) but reduced the antinociceptive effect of paracetamol (50-200 mg/kg). This effect was significant (P<0.05) for the highest dose (200 mg/kg) of paracetamol (Fig. 3B,C) .
In a further series of experiments caffeine and paracetamol were administered to A 2A receptor knockout mice, but the basal response latency of all knockout mice prior to drug administration was 11.35 ± 0.41 s, significantly higher than the wildtype control (P<0.05). Paracetamol even at high doses (100-200 mg/kg) and caffeine (10 mg/kg) administered alone or in combination failed to increase nociceptive response latencies further.
The effect of SCH58261 and PSB1115 on the antinociceptive response to paracetamol in the hot plate test.
Paracetamol (50 mg/kg) or the A 2A antagonist SCH58261 (3 mg/kg) administered alone produced significant antinociception, but in the presence of SCH58261 (3 mg/kg) paracetamol (50 mg/kg) was unable to increase response latency further (Fig.   4A ). The A 2B antagonist PSB1115 (10 mg/kg) administered alone induced a very small antinociceptive response that only achieved significance at 45 min (P<0.05).
The combination of paracetamol (50 mg/kg) and PSB1115 (10 mg/kg) produced antinociception that was significantly greater than paracetamol alone (Fig. 4B) .
Discussion
Although other studies have reported the effect of high doses of paracetamol (400 mg/kg) (Pini et al., 1996; Srikiatkhachorn et al., 1999; Sandrini et al., 2001; Bonnefont et al., 2003) , we did not study doses above 200 mg/kg because of the known toxic effects (Tee et al., 1987; Gardner et al., 2002) . Caffeine at a dose of 40 mg/kg has previously been shown to have an antinociceptive effect in the hot plate test when combined with paracetamol (Engelhardt et al., 1997) . We also found an antinociceptive effect of 40 mg/kg caffeine in the tail immersion and hot plate test (data not shown) but doses at this level have questionable relevance to its use as an analgesic adjuvant in humans. As lower doses of caffeine have also been shown to exert an antinociceptive effect (Sawynok et al., 1995; Ghelardini et al., 1997; AboSalem et al., 2004) , 10 mg/kg caffeine was chosen for the majority of the experiments. (2004)), factors that could underlie the difference in the observed effects of caffeine (Wilson and Mogil, 2001 ). We used the higher temperature to ensure a supraspinal component to this antinociceptive test. This emphasises the importance of the experimental model, and suggests that the effects of caffeine may be highly dependent on the nature of the nociceptive stimulus.
SCH58261 is a specific antagonist of the adenosine A 2A receptor (Zocchi et al., 1996) that has been shown to have antinociceptive effects in CD1 mice in the hot plate test (52°C), but only when administered intrathecally, and not when administered i.p. (Bastia et al., 2002) . However in the experiments reported here SCH58261 (3 mg/kg) administered i.p. produced antinociception in the hot plate test (55°C), and this difference again may reflect the temperature or the nociceptive end point used. We chose paw licking rather than jumping, which has been suggested to be a more sensitive and reliable nociceptive response than jumping (Wilson and Mogil, 2001 ).
We also observed antinociceptive effects of SCH58261 in the tail immersion test (53 °C) when administered i.p. The antinociceptive effect of the A 2A antagonist, together with the hypoalgesia seen in the A 2A receptor knockout mice both in this study and previously (Ledent et al., 1997; Bailey et al., 2002a ) confirms a pronociceptive role for adenosine A 2A receptors. We did not observe any further effect of paracetamol, caffeine or combinations of the two in either test in the knockout mice, probably because the increased nociceptive threshold in the knockouts masked any effects of the drugs. Similarly, paracetamol was not able to induce a further increase in response latency in the presence of SCH58261.
PSB1115 is a specific antagonist with 180-fold selectivity for human adenosine A 2B receptor compared to the rat adenosine A 2A receptor, that has been suggested to be unlikely to penetrate into the central nervous system due to its polar nature (Hayallah et al., 2002) . Abo-Salem et al (2004) reported that PSB1115 at 10 mg/kg did not produce significant antinociception by itself in the hot plate test, but significantly 
